GDRX
NASDAQ · Health Care
Goodrx Holdings Inc-Class A
$3.39
+0.01 (+0.30%)
Financial Highlights (FY 2026)
Revenue
761.54M
Net Income
29.10M
Gross Margin
92.8%
Profit Margin
3.8%
Rev Growth
+1.3%
D/E Ratio
0.79
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 92.8% | 92.8% | 36.5% | 36.5% |
| Operating Margin | 11.0% | 9.9% | 9.8% | 10.6% |
| Profit Margin | 3.8% | 3.6% | 8.2% | 9.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 761.54M | 751.77M | 348.02M | 354.36M |
| Gross Profit | 706.48M | 697.41M | 126.97M | 129.28M |
| Operating Income | 83.62M | 74.29M | 34.23M | 37.71M |
| Net Income | 29.10M | 25.85M | 28.69M | 32.45M |
| Gross Margin | 92.8% | 92.8% | 36.5% | 36.5% |
| Operating Margin | 11.0% | 9.9% | 9.8% | 10.6% |
| Profit Margin | 3.8% | 3.6% | 8.2% | 9.2% |
| Rev Growth | +1.3% | +1.3% | +17.9% | +14.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 255.62M | 255.62M | 344.40M | 295.15M |
| Total Equity | 322.63M | 322.63M | 683.48M | 611.71M |
| D/E Ratio | 0.79 | 0.79 | 0.50 | 0.48 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 165.05M | 154.78M | 58.27M | 51.67M |
| Free Cash Flow | — | — | 25.71M | 22.62M |